Replies to post #68077 on Biotech Values

[DewDiligence]

Re: ACUS

Good for them to have gotten a 20% rate. However, it’s bizarre to hear management insist on the CC that the royalty rate can’t be disclosed, only to find that it is disclosed after all in the SEC filing.